George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Thanks Chaps, that info was just what I was looking for ??
Before I get my excel out and start tallying up the RNS has anyone being keeping a tally on the buy back progress?
Unfortunate indeed. On the plus side, DLG can buy back more stocks cheaper as part of their buy back program.
No technical resistance I can see at 174p... More likely mental one with people not wanting to pay over placing.
I believe its earlier the better. Biologically INF is the first line of defence (0 to 3 days) so the sooner the better, is what I heard.
Thanks MDT10 didn’t have energy to write that. If you really want to operate with long sight, get a new one every year with a different provider so you have growth to 85k per ISA operator, which will give you FSCS protection against bank bust (2008 style).
Agree dumb for those generally not affected i.e. city wide testing, schools, uni's and healthy ages with no comorbidities. But cannot agree with them at care homes. Effective rate is 76% I read. Well sorry but it only takes one in 4 infected to get it into a carehome and watch it rip through the residents once again.
Low risk groups (inc - those they interact with) = LTF
High risk groups, or those working with high risk = PCR
as far as I'm concerned.
Woody, I did some thinking on this today and came to 1.8b MCAP buyout myself. Let’s hope it’s a sign... at least better than the 67p WSG dream I had once (still waiting only 61p to go).
More than one post.
Aligned with CR1909, Richard even mentions being across the globe in his proactive interview, so they can test in differing socio economic settings, ethnicities, and healthcare settings.
I'm hoping with all the free money being printed by BOE, then WSG can get any additional finance with somewhat better terms.
My view is when Iran are back to the table talking, and covid has passed we may well get some opportunities but not until they are playing nicely, and international travel has rebounded enough that westerners care to travel to Iran and need to feel safe doing so, especially after they managed to shoot a passenger plane down.
At that point we could bring some credibility in leveling them up to international standards. 18 to 24 month horizon on that for me. That said I do believe this rise is just on the C19 sales and Tema/SL MRR coming in.
Agree that US now caring about "Covid Safe" under Biden could open up international sales too.
Chantico - I thought the placing shares had a 180 day clause, so how can they be flipped?
https://www.tendersinfo.com/details/457525203
Wonder if the freebee's put us in good light for this RFP for security kit.
4th of Nov
Seems a lot more chatter on WSG on Twitter Friday/this morning.
The participant received the placebo, trial is now back on as a result. Usual sensational headline grabbing garbage. Doesn’t help the world against the anti vaxers and flat earthers...
I’ll decide about taking my share on the 27th depending what price we are at. Incase of any drops or drifts between now and then, I’ve got a nice pot ready for another top up @ or below 175
That’s a great shout and a very plausible outcome I’d say...
Assuming all the authorisations come in and the data, etc. What relationships do we have left to establish?
We obviously have: -
- Manufacturer of molecule
- Packager into doses
- Nebulizer selected
Whats that leave to be announced to fill out our supply chain?: -
- Distributor
- Sales entity (would we need one or will it sell its self)
What am I missing, just trying to figure what other lower level RNS' might we get?